Epilepsy surgery in Africa: state of the art and challenges.


Journal

Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858

Informations de publication

Date de publication:
05 2021
Historique:
received: 31 12 2020
revised: 24 02 2021
accepted: 25 02 2021
pubmed: 22 3 2021
medline: 19 5 2021
entrez: 21 3 2021
Statut: ppublish

Résumé

Epilepsy is an important public health problem representing 0.6% of the global burden of disease that particularly impacts people living in the lowest income countries where epilepsy incidence may be 10 fold more than in the developed world. The battery of treatments designed to counteract the clinical manifestations of this disease are various and range from a wide spectrum of antiseizure medicationand specific diets, to surgical techniques for resection of the epileptogenic focus. The aim of our study was to describe the State of the art of Epilepsy Surgery (ES) in Africa and examine ways to deal with the high surgical treatment gap. In an observational study, we prospectively disseminated questionnaires via email or directly administered to main epileptologists and neurologists involved in epilepsy care, in key African countries. We also conducted a literature search using PubMed, Google scholar on ES in all the African countries. We received responses from the majority of African countries, which allowed us to identify 3 levels of care for ES in African countries, a first level that uses ES with invasive presurgical evaluation, a second level that uses ES but without invasive presurgical evaluation, and a third level that does not use ES, and we summarized these results on a map. This paper studied the availability of ES as a treatment modality in several African countries. We aimed to establish optimal pathways for initiating ES with noninvasive Electroencephalography and readily available investigations. This could be achieved through collaboration with epilepsy programs in developed countries directly or by using telemedicine.

Identifiants

pubmed: 33744795
pii: S1525-5050(21)00144-X
doi: 10.1016/j.yebeh.2021.107910
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

107910

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Najib Kissani (N)

Laboratory of Clinical and Experimental Neuroscience. Faculty of Medicine, Cadi Ayyad University, Marrakech, Morocco; Department of Neurology. University Teaching, Hospital Mohammed VI, Marrakesh, Morocco. Electronic address: najibkis@gmail.com.

Sanaa Nafia (S)

Laboratory of Clinical and Experimental Neuroscience. Faculty of Medicine, Cadi Ayyad University, Marrakech, Morocco.

Abdelaati El Khiat (A)

Laboratory of Clinical and Experimental Neuroscience. Faculty of Medicine, Cadi Ayyad University, Marrakech, Morocco.

Noureddine Bengamara (N)

Privat Neurology Clinic, Oran, Algeria.

Youssoufa Maiga (Y)

Neurology Department, Hospital Gabriel Touré, Bamako, Mali.

Youssouf Sogoba (Y)

Neurosurgery Department, Hospital Gabriel Touré, Bamako, Mali.

Eetedal Ahmed A Ibrahim (E)

Neurology Department. Alneelain University, National Centre for Neurological Centre, Khartoum, Sudan.

Mendinatou Agbetou (M)

Neurology Department, University of Parakou, Benin.

Gams Massi Daniel (G)

Neurology Unit, Douala General Hospital, Cameroon.

Komi Assogba (K)

Neurology Department, University Hospital, Campus of Lome, Togo.

Ndiaga Matar Gaye (N)

Neurology Department of Fann Teaching Hospital, Dakar, Senegal.

Callixte Kuate Tegueu (C)

Neurology Department, Laquintinie Hospital of Douala, Cameroun.

Amany Hussein Ragab (A)

Neurology Department, Cairo University, Egypt.

Julien Razafimahefa (J)

Neurology Unit of Befelatanana Hospital, Antananarivo, Madagascar.

Jo Wilmshurst (J)

Head of Paediatric Neurology, Red Cross War Memorial Children's Hospital, University of Cape Town, South Africa.

Ansuya Naidoo (A)

Head of Clinical Unit and Consultant Neurologist (Greys Academic Hospital) Clinical Lecturer, South Africa.

John N Jabang (JN)

Neurosurgery Unit, Department of Surgery, Edward Francis Small Teaching Hospital, Banjul, Gambia.

Musa Watila (M)

Neurology Unit, Department of Medicine, University of Maiduguri Teaching Hospital, PMB 1414, Maiduguri, Borno State, Nigeria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH